Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) EBIT: 2020-2024

Historic EBIT for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to -$49.0 million.

  • Burning Rock Biotech's EBIT rose 65.61% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.7 million, marking a year-over-year increase of 75.66%. This contributed to the annual value of -$49.0 million for FY2024, which is 48.04% up from last year.
  • Per Burning Rock Biotech's latest filing, its EBIT stood at -$49.0 million for FY2024, which was up 48.04% from -$94.3 million recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's EBIT registered a high of -$49.0 million during FY2024, and its lowest value of -$142.1 million during FY2022.
  • Over the past 3 years, Burning Rock Biotech's median EBIT value was -$94.3 million (recorded in 2023), while the average stood at -$95.1 million.
  • As far as peak fluctuations go, Burning Rock Biotech's EBIT crashed by 97.89% in 2021, and later skyrocketed by 48.04% in 2024.
  • MRY analysis of 5 years shows Burning Rock Biotech's EBIT stood at -$63.2 million in 2020, then tumbled by 97.89% to -$125.1 million in 2021, then decreased by 13.65% to -$142.1 million in 2022, then skyrocketed by 33.68% to -$94.3 million in 2023, then skyrocketed by 48.04% to -$49.0 million in 2024.
  • Its EBIT stands at -$49.0 million for FY2024, versus -$94.3 million for FY2023 and -$142.1 million for FY2022.